Literature DB >> 23612974

Cleavage activation of human-adapted influenza virus subtypes by kallikrein-related peptidases 5 and 12.

Brian S Hamilton1, Gary R Whittaker.   

Abstract

A critical step in the influenza virus replication cycle is the cleavage activation of the HA precursor. Cleavage activation of influenza HA enables fusion with the host endosome, allowing for release of the viral genome into the host cell. To date, studies have determined that HA activation is driven by trypsin-like host cell proteases, as well as yet to be identified bacterial proteases. Although the number of host proteases that can activate HA is growing, there is still uncertainty regarding which secreted proteases are able to support multicycle replication of influenza. In this study, we have determined that the kallikrein-related peptidases 5 and 12 are secreted from the human respiratory tract and have the ability to cleave and activate HA from the H1, H2, and H3 subtypes. Each peptidase appears to have a preference for particular influenza subtypes, with kallikrein 5 cleaving the H1 and H3 subtypes most efficiently and kallikrein 12 cleaving the H1 and H2 subtypes most efficiently. Cleavage analysis using HA cleavage site peptide mimics revealed that the amino acids neighboring the arginine cleavage site affect cleavage efficiency. Additionally, the thrombolytic zymogens plasminogen, urokinase, and plasma kallikrein have all been shown to cleave and activate influenza but are found circulating mainly as inactive precursors. Kallikrein 5 and kallikrein 12 were examined for their ability to activate the thrombolytic zymogens, and both resulted in activation of each zymogen, with kallikrein 12 being a more potent activator. Activation of the thrombolytic zymogens may therefore allow for both direct and indirect activation of the HA of human-adapted influenza viruses by kallikrein 5 and kallikrein 12.

Entities:  

Keywords:  Hemagglutinin; Influenza Virus; Kallikrein; Membrane Fusion; Protease; Serine Protease

Mesh:

Substances:

Year:  2013        PMID: 23612974      PMCID: PMC3682540          DOI: 10.1074/jbc.M112.440362

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes.

Authors:  J D Hooper; J A Clements; J P Quigley; T M Antalis
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Sialic acid species as a determinant of the host range of influenza A viruses.

Authors:  Y Suzuki; T Ito; T Suzuki; R E Holland; T M Chambers; M Kiso; H Ishida; Y Kawaoka
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator.

Authors:  D Belin; J D Vassalli; C Combépine; F Godeau; Y Nagamine; E Reich; H P Kocher; R M Duvoisin
Journal:  Eur J Biochem       Date:  1985-04-15

4.  KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.

Authors:  G M Yousef; A Magklara; E P Diamandis
Journal:  Genomics       Date:  2000-11-01       Impact factor: 5.736

Review 5.  Cardiovascular properties of the kallikrein-kinin system.

Authors:  Jagdish N Sharma; Jyoti Sharma
Journal:  Curr Med Res Opin       Date:  2002       Impact factor: 2.580

6.  Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus.

Authors:  Claudia Pappas; Patricia V Aguilar; Christopher F Basler; Alicia Solórzano; Hui Zeng; Lucy A Perrone; Peter Palese; Adolfo García-Sastre; Jacqueline M Katz; Terrence M Tumpey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

7.  Role of Staphylococcus protease in the development of influenza pneumonia.

Authors:  M Tashiro; P Ciborowski; H D Klenk; G Pulverer; R Rott
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

8.  A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.

Authors:  Chris Planque; Lin Li; Yingye Zheng; Antoninus Soosaipillai; Karen Reckamp; David Chia; Eleftherios P Diamandis; Lee Goodglick
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

Review 9.  Cell surface remodeling by plasmin: a new function for an old enzyme.

Authors:  Elena I Deryugina; James P Quigley
Journal:  J Biomed Biotechnol       Date:  2012-10-14

Review 10.  Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic.

Authors:  Rafi Ahmed; Michael B A Oldstone; Peter Palese
Journal:  Nat Immunol       Date:  2007-11       Impact factor: 25.606

View more
  21 in total

Review 1.  Kallikreins - The melting pot of activity and function.

Authors:  Magdalena Kalinska; Ulf Meyer-Hoffert; Tomasz Kantyka; Jan Potempa
Journal:  Biochimie       Date:  2015-09-25       Impact factor: 4.079

2.  Kallikrein-Related Peptidase 5 Contributes to H3N2 Influenza Virus Infection in Human Lungs.

Authors:  Mélia Magnen; Fabien Gueugnon; Antoine Guillon; Thomas Baranek; Virginie C Thibault; Agnès Petit-Courty; Simon J de Veer; Jonathan Harris; Alison A Humbles; Mustapha Si-Tahar; Yves Courty
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

3.  Modification of the hemagglutinin cleavage site allows indirect activation of avian influenza virus H9N2 by bacterial staphylokinase.

Authors:  Longping V Tse; Gary R Whittaker
Journal:  Virology       Date:  2015-04-01       Impact factor: 3.616

Review 4.  Putative functions of tissue kallikrein-related peptidases in vaginal fluid.

Authors:  Carla M J Muytjens; Stella K Vasiliou; Katerina Oikonomopoulou; Ioannis Prassas; Eleftherios P Diamandis
Journal:  Nat Rev Urol       Date:  2016-09-07       Impact factor: 14.432

5.  Kallistatin ameliorates influenza virus pathogenesis by inhibition of kallikrein-related peptidase 1-mediated cleavage of viral hemagglutinin.

Authors:  Chia-Hsing Leu; Mei-Lin Yang; Nai-Hui Chung; Yen-Jang Huang; Yu-Chu Su; Yi-Cheng Chen; Chia-Cheng Lin; Gia-Shing Shieh; Meng-Ya Chang; Shainn-Wei Wang; Yao Chang; Julie Chao; Lee Chao; Chao-Liang Wu; Ai-Li Shiau
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

6.  TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.

Authors:  Hannah Limburg; Anne Harbig; Dorothea Bestle; David A Stein; Hong M Moulton; Julia Jaeger; Harshavardhan Janga; Kornelia Hardes; Janine Koepke; Leon Schulte; Andreas Rembert Koczulla; Bernd Schmeck; Hans-Dieter Klenk; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

7.  Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways.

Authors:  Manon Laporte; Annelies Stevaert; Valerie Raeymaekers; Talitha Boogaerts; Inga Nehlmeier; Winston Chiu; Mohammed Benkheil; Bart Vanaudenaerde; Stefan Pöhlmann; Lieve Naesens
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

8.  Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.

Authors:  Anne Harbig; Marco Mernberger; Linda Bittel; Stephan Pleschka; Klaus Schughart; Torsten Steinmetzer; Thorsten Stiewe; Andrea Nist; Eva Böttcher-Friebertshäuser
Journal:  J Biol Chem       Date:  2020-04-17       Impact factor: 5.157

9.  TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice.

Authors:  Carolin Tarnow; Géraldine Engels; Annika Arendt; Folker Schwalm; Hanna Sediri; Annette Preuss; Peter S Nelson; Wolfgang Garten; Hans-Dieter Klenk; Gülsah Gabriel; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  Inhibition of influenza virus infection and hemagglutinin cleavage by the protease inhibitor HAI-2.

Authors:  Brian S Hamilton; Changik Chung; Soreen Y Cyphers; Vera D Rinaldi; Valerie C Marcano; Gary R Whittaker
Journal:  Biochem Biophys Res Commun       Date:  2014-06-27       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.